Averna Therapeutics Inc.

CIK 2020048 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Averna Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Mar 20, 2026D/A0002020048-26-000004
Apr 21, 2025D/A0000911420-25-000115
Apr 17, 2024D0000911420-24-000092